Study Evaluating SC262 in Subjects With r/r Non-Hodgkin's Lymphoma (VIVID)
Clinical trial NCT06285422 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06285422
- Sponsor
- Sana Biotechnology
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-18
- Primary completion
- 2025-12-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.